<h3>Episode 1: «Inbound Cross-border Fund Offerings»</h3>
<p>In this episode <a href="https://www.homburger.ch/en/team/jurg-frick/">Jürg Frick</a> and <a href="https://www.homburger.ch/en/team/vanessa-isler/">Vanessa Isler</a> discuss what foreign funds and their distributors have to keep in mind when they are looking to approach Swiss investors, with a special focus on when a foreign fund or distributor may be providing a financial service under FinSA.</p>


<h3>Episode 2: «Ansässigkeit»</h3>
<p>The FinSA newly regulates the cross-border provision of financial services in Switzerland. When is a foreign financial services provider considered to be based in Switzerland? Under which circumstances do its client advisors have to be registered in Switzerland? And what sanctions apply in case of non-compliance with these rules?</p>
<p>In this episode, <a href="https://www.homburger.ch/en/team/benedikt-maurenbrecher/">Benedikt Maurenbrecher</a> and <a href="https://www.homburger.ch/en/team/stefan-bindschedler/">Stefan Bindschedler</a> answer these and other questions.</p>


<h3>Episode 3: «Reverse Solicitation»</h3>
<p>Financial services rendered by foreign financial services providers at a Swiss client’s own exclusive initiative are not subject to the Financial Services Act («reverse solicitation»). But what exactly are the conditions for the financial services provider to be able to rely on the exemption? And how does reverse solicitation play out within the context of the offering of financial instruments?</p>
<p>Join <a href="https://www.homburger.ch/en/team/stefan-kramer/">Stefan Kramer</a> and <a href="https://www.homburger.ch/en/team/manuel-baschung/">Manuel Baschung</a> for a primer on these and other questions.</p>


<h3>Episode 4: «On Tour with Investors»</h3>
<p>What has to be done – or avoided – when going on a road show to meet potential or existing shareholders or other investors in Switzerland? <a href="https://www.homburger.ch/en/team/david-borer/">David Bore</a>r and <a href="https://www.homburger.ch/en/team/benjamin-leisinger/">Benjamin Leisinger</a> will explain the «dos &amp; don&#8217;ts» when it comes to road shows under the Financial Services Act, in particular as to the concepts of «advertising», the «provision of financial services» and an «offer».</p>


<h3>Episode 5: «Robo Advisors in Switzerland – Regulatory Framework»</h3>
<p>Robo Advisors increasingly gain traction in Switzerland and have been able to record a substantial growth in their assets under management in recent years.</p>
<p>In view of these developments, <a href="https://www.homburger.ch/en/team/hansjurg-appenzeller/">Hansjürg Appenzeller</a> and <a href="https://www.homburger.ch/en/team/alexander-wherlock/">Alexander Wherlock</a> will be giving a comprehensive overview of the regulatory requirements applicable to Robo Advisors conducting business in Switzerland.</p>


<h3>Episode 6: «Retrozessionen»</h3>
<p>Is FinSA a «game changer» for retrocessions? What is the role of general terms and conditions? And can existing waivers be used going forward? In this episode, <a href="https://www.homburger.ch/en/team/katrin-ivell/">Katrin Ivell</a> and <a href="https://www.homburger.ch/en/team/fabrice-eckert/">Fabrice Eckert</a> provide answers to these and other questions.</p>


<h3>&gt; <a href="https://www.homburger.ch/en/financial-market-regulation-hub/">Visit our Hub with a compilation of our publications and more on financial market regulation.</a></h3>


fidleg_preview_final_02

Update<br>FIDLEG Mini Series<br>Episodes 1–6

Corporate / M&A

Capital Markets

Financing and Investment Products

IP / IT

Data Protection

Employment and Executive Compensation

Competition

Regulatory

Vectivio

Homburger News

Share-Image Teamplate Deals-and-Cases

<p>On May 22, 2023, VectivBio Holding AG (Nasdaq: VECT), Basel (Switzerland), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an all-cash public tender offer to acquire all outstanding shares in VectivBio for USD 17 per share, with an estimated aggregate consideration of approximately USD 1 bn, net of VectivBio cash and debt. The acquisition price represents a premium of 80% relative to the volume-weighted average share price over the previous 90 trading days. The offer is subject to customary conditions and expected to close in mid-2023. VectivBio&#8217;s board of directors unanimously recommends the offer. Orbimed, Forbion and Versant Ventures, and VectivBio&#8217;s directors and officers jointly representing 28.6% of VectivBio&#8217;s shareholdings, entered into tender and support agreements in connection with, and in support of, the offer.</p>
<p>Homburger AG serves as legal and tax advisor to VectivBio on the transaction. The Homburger team includes Andreas Müller, Margrit Marti, Oliver Kneubühl, Francesco Bernasconi, Oliver Dalla Palma, Daniel Wenzinger and Carolina Rodriguez (all Corporate / M&amp;A), Lorenzo Togni (Capital Markets), Stefan Oesterhelt, Philippe Gobet and Kevin Müller (all Tax), Stefan Bindschedler (Financing and Investment Products), Luca Dal Molin (IP / IT; Data Protection), Angela Casey (Employment and Executive Compensation), and Richard Stäuber and Christoph Grüninger (Competition, Regulatory).</p>


Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Swarovski

<p>Homburger acted as counsel to Swarovski International Holding AG in connection with the extension of its revolving credit facility, arranged by, amongst others, UBS Switzerland AG and Credit Suisse (Switzerland) Ltd.</p>
<p>Homburger advised Swarovski International Holding AG and its subsidiaries with regard to all Swiss legal aspects of the financing transaction.</p>
<p>The Homburger team was led by partner Jürg Frick (Financing and Investment Products) and included partner Stefan Oesterhelt (Tax) as well as associate Stefan Bindschedler (Financing and Investment Products).</p>


Homburger advised Swarovski International Holding AG with regard to the extension of its revolving credit facility

Homburger for Valaris

<p>On April 19, 2023, Valaris Limited and its wholly-owned subsidiary, Valaris Finance Company LLC, closed the private placement of USD 700 m 8.375% senior secured second lien notes due 2030 and a senior secured first lien five-year credit agreement providing for commitments of up to USD 375 m. Valaris Limited is the industry leader in offshore drilling services across all water depths and geographies.</p>
<p>Homburger advised Valaris Limited with regard to all Swiss legal aspects of the transaction. The Homburger team was led by David Oser (Corporate/M&amp;A) and included Daniel Haeberli and Stefan Bindschedler (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax).</p>


Stefan
Bindschedler

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Homburger advised Swarovski International Holding AG with regard to the extension of its revolving credit facility

Homburger advised Valaris Limited on the private placement of USD 700 m senior secured notes and an up to USD 375 m credit agreement

Update
FIDLEG Mini Series
Episodes 1–6

Corporate Insolvency & Restructuring Report 2021: Switzerland

Corporate Insolvency & Restructuring Report 2020: Covid-19 Special Focus: Switzerland

Join the Team

Stefan Bindschedler

Career

Languages

Bar Registration

Teams

StefanBindschedler

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

Homburger advised Swarovski International Holding AG with regard to the extension of its revolving credit facility

Homburger advised Valaris Limited on the private placement of USD 700 m senior secured notes and an up to USD 375 m credit agreement

UpdateFIDLEG Mini SeriesEpisodes 1–6

Corporate Insolvency & Restructuring Report 2021: Switzerland

Corporate Insolvency & Restructuring Report 2020: Covid-19 Special Focus: Switzerland

Join the Team

Stefan Bindschedler

Career

Languages

Bar Registration

Teams

Stefan
Bindschedler

Update
FIDLEG Mini Series
Episodes 1–6